Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment


Autoria(s): Treanor, Charlene J.; Cantwell, Marie; Cardwell, Christopher R.; Clarke, Mike J.; Donnelly, Michael
Data(s)

07/10/2014

Resumo

This is the protocol for a review and there is no abstract. The objectives are as follows:<br/><br/>The primary objective of this review is to evaluate the effects of non-pharmacological interventions among cancer patients targeted at maintaining cognitive function or ameliorating cognitive impairment as a result of cancer or receipt of systemic cancer treatment (i.e. chemotherapy or hormonal therapies in isolation or combination with other treatments). Patients who have received treatments such as cranial radiation for central nervous system tumours or metastases are not the focus of this review and will be excluded.<br/><br/>A second objective is to evaluate the effectiveness of non-pharmacological interventions for improving non-cognitive outcomes e.g. quality of life among this population.<br/><br/>Thirdly, we will extract and analyse data regarding the duration of intervention effects.<br/><br/>Fourthly, we will examine each study to identify safety as an outcome and incorporate information on intervention safety where possible. Evidence for the review will be based on data from randomised trials.<br/><br/>

Identificador

http://pure.qub.ac.uk/portal/en/publications/nonpharmacological-interventions-for-cognitive-impairment-due-to-systemic-cancer-treatment(f260b89a-e8b2-4c9c-970a-2e205d68c212).html

http://dx.doi.org/10.1002/14651858.CD011325

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Cochrane Gynaecological Cancer Group 2014 , ' Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment ' Cochrane database of systematic reviews (Online) , no. 10 , CD011325 . DOI: 10.1002/14651858.CD011325

Tipo

article